Mesa Laboratories Inc (MLAB) — 13F Filings Explorer (Q2 2026)

MLAB ranks #3540 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

MLAB is a disclosed holding of Cliff Asness (AQR Capital Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

MLAB is a top-conviction position for Long Path Partners LP — at 20.2% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

Wasatch Advisors LP has added to its MLAB position for two straight quarters, increasing it by $45.8M to reach $50.3M today.

Essential Partners LLC has trimmed its MLAB position for two straight quarters, cutting it by $4.7K while still holding $6.2K.

MLAB is down 4.1% today, but institutions show net buying of $70.1M this quarter — a divergence between today's price move and the underlying institutional flow.

MLAB posted net income of $4.8M over the trailing twelve months, and currently trades at a P/E of 142.0.

• Profitable — net income of $4.8M over the trailing twelve months
• Revenue grew 3.0% year over year
• Net income improved year over year, from -$620.0K to $4.8M
• Generated $42.8M in positive operating cash flow
• Current ratio of 1.72x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.30x equity — within a conventional range